An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
Clinical trial NCT02128334 · COMPLETED
Trial details
- NCT number
- NCT02128334
- Sponsor
- Astellas Pharma Europe B.V.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-09-01
- Primary completion
- 2016-03-01
- Enrollment
- 645
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.